Jinxu Li
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Jinxu Li has a total of 23 co-authors. Here are the top co-authors by number of shared publications:
- Lu Tang
Texas A&M University
6 shared publications - Sophia Fantus
University of Texas at Arlington
3 shared publications Jing Zeng
Department of Communication Arts and Sciences, Pennsylvania State University
2 shared publications- Tianci Wang
Burnett School of Medicine, Texas Christian University, Fort Worth, TX, United States
2 shared publications Anli Xiao
University of South Carolina, Columbia, USA
1 shared publication- Ann Neville Miller
University of Central Florida
1 shared publication
Latest Publications
- 1 September 2026
- Published by Taylor & Francis in Mass Communication and Society
- p. 1-21
Leveraging Facebook for Mental Health Promotion: The Role of Information Acquisition, Social Support, and Belongingness Among Asian Americans
Facebook, one of the most widely used social media platforms, has become a key space for acquiring health information and engaging in health-related activities (Alber et al., 2018; Mohsin et al., 2...
- 1 September 2026
- Published by Taylor & Francis in Mass Communication and Society
- p. 1-21
Leveraging Facebook for Mental Health Promotion: The Role of Information Acquisition, Social Support, and Belongingness Among Asian Americans
Facebook, one of the most widely used social media platforms, has become a key space for acquiring health information and engaging in health-related activities (Alber et al., 2018; Mohsin et al., 2...
- 21 July 2026
- Published by Taylor & Francis in Arts & Health
- p. 1-16
Moving with meaning: community line dancing, health-motivated engagement, and belonging among older adults in Texas
As the U.S. population ages, promoting both physical and psychological well-being among older adults has become a pressing public health priority. Over the next four decades, the population aged 65...
- 21 July 2026
- Published by Taylor & Francis in Arts & Health
- p. 1-16
Moving with meaning: community line dancing, health-motivated engagement, and belonging among older adults in Texas
As the U.S. population ages, promoting both physical and psychological well-being among older adults has become a pressing public health priority. Over the next four decades, the population aged 65...
- 9 June 2026
- Published by Taylor & Francis in Journal of Health Communication
- Vol. 31 (7) , 1-12
The Path to Compliance: Exploring the Roles of Trust, Positive Expectancy Violation, and eHealth Literacy in Online Patient-Centered Communication
In China, health disparity primarily arises from the uneven distribution of healthcare resources (Yu et al., 2019). For example, rural areas face fewer healthcare facilities and a shortage of quali...
- 9 June 2026
- Published by Taylor & Francis in Journal of Health Communication
- Vol. 31 (7) , 1-12
The Path to Compliance: Exploring the Roles of Trust, Positive Expectancy Violation, and eHealth Literacy in Online Patient-Centered Communication
In China, health disparity primarily arises from the uneven distribution of healthcare resources (Yu et al., 2019). For example, rural areas face fewer healthcare facilities and a shortage of quali...
- Open Access
- 27 February 2026
- Published by SAGE Publications in Journal of Health Psychology
- Vol. 31 (12) , 4899-4919
Using the misinformation exposure-trust framework for audience segmentation: Predicting COVID-19 vaccine hesitancy among U.S. College Students
This study examines whether individuals’ exposure to and trust in COVID-19 vaccine misinformation can be used to segment audiences and explain variations in vaccine hesitancy and health beliefs. Using k-means clustering, a survey of 819 U.S. college students (March–May 2021) identifies four subgroups based on combinations of high or low misinformation exposure and trust: misinformation-shielded (low exposure, low trust), misinformation-vulnerable (low exposure, high trust), misinformation-resistant (high exposure, low trust), and misinformation-accepting (high exposure, high trust). These subgroups differ significantly in political ideology, vaccine hesitancy, and health beliefs. The misinformation-shielded subgroup reports more liberal views, lower hesitancy, and higher perceived efficacy, whereas the misinformation-vulnerable and misinformation-accepting subgroups perceive lower vaccine safety. Regression analyses show that perceived vaccine efficacy and perceived vaccine safety are relatively stable predictors of vaccine hesitancy. The misinformation exposure-trust framework offers a theory-based strategy for segmenting audiences and informs more targeted health interventions.
- 27 February 2026
- Published by SAGE Publications in Journal of Health Psychology
- Vol. 31 (12) , 4899-4919
Open AccessUsing the misinformation exposure-trust framework for audience segmentation: Predicting COVID-19 vaccine hesitancy among U.S. College Students
This study examines whether individuals’ exposure to and trust in COVID-19 vaccine misinformation can be used to segment audiences and explain variations in vaccine hesitancy and health beliefs. Using k-means clustering, a survey of 819 U.S. college students (March–May 2021) identifies four subgroups based on combinations of high or low misinformation exposure and trust: misinformation-shielded (low exposure, low trust), misinformation-vulnerable (low exposure, high trust), misinformation-resistant (high exposure, low trust), and misinformation-accepting (high exposure, high trust). These subgroups differ significantly in political ideology, vaccine hesitancy, and health beliefs. The misinformation-shielded subgroup reports more liberal views, lower hesitancy, and higher perceived efficacy, whereas the misinformation-vulnerable and misinformation-accepting subgroups perceive lower vaccine safety. Regression analyses show that perceived vaccine efficacy and perceived vaccine safety are relatively stable predictors of vaccine hesitancy. The misinformation exposure-trust framework offers a theory-based strategy for segmenting audiences and informs more targeted health interventions.
- Open Access
- 28 January 2026
- Published by JMIR Publications Inc. in Journal of Medical Internet Research
- Vol. 28, e79613
Ethical Knowledge, Challenges, and Institutional Strategies Among Medical AI Developers and Researchers: Focus Group Study
Background: As artificial intelligence (AI) becomes increasingly embedded in clinical decision-making and preventive care, it is urgent to address ethical concerns such as bias, privacy, and transparency to protect clinician and patient populations. Although prior research has examined the perspectives of medical AI stakeholders, including clinicians, patients, and health system leaders, far less is known about how medical AI developers and researchers understand and engage with ethical challenges as they develop AI tools. This gap is consequential because developers’ ethical awareness, decision-making, and institutional environments influence how AI tools are conceptualized and deployed in practice. Thus, it is essential to understand how developers perceive these issues and what supports they identify as necessary for ethical AI development. Objective: The objectives of the study were twofold: (1) to examine medical AI developers’ and researchers’ knowledge, attitudes, and experiences with AI ethics; and (2) to identify recommendations to enhance and strengthen interpersonal and institutional ethics-focused training and support. Methods: We conducted 2 semistructured focus groups (60-90 minutes each) in 2024 with 13 AI developers and researchers affiliated with 5 US-based academic institutions. Participants’ work spanned a wide variety of medical AI applications, including Alzheimer disease prediction, clinical imaging, electronic health records analysis, digital health, counseling and behavioral health, and genotype–phenotype modeling. Focus groups were conducted via Microsoft Teams, recorded, and transcribed verbatim. We applied conventional qualitative content analysis to inductively identify emerging concepts, categories, and themes. Coding was performed independently by 3 researchers, with consensus reached through iterative team meetings. Results: The analysis identified four key themes: (1) AI ethics knowledge acquisition: participants reported learning about ethics informally through peer-reviewed literature, reviewer feedback, social media, and mentorship rather than through structured training; (2) ethical encounters: participants described recurring ethical challenges related to data bias, patient privacy, generative AI use, commercialization pressures, and a tendency for research environments to prioritize model accuracy over ethical reflection; (3) reflections on ethical implications: participants expressed concern about downstream effects on patient care and clinician autonomy, and model generalizability, noting that rapid technological innovation outpaces regulatory and evaluative processes; and (4) strategies to mitigate ethical concerns: recommendations included clearer institutional guidelines, ethics checklists, interdisciplinary collaboration, multi-institutional data sharing, enhanced institutional review board support, and the inclusion of bioethicists as members of the AI research team. Conclusions: Medical AI developers and researchers recognize significant ethical challenges in their work but lack structured training, resources, and institutional mechanisms to address them. Findings of this study underscore the need for institutions to consider embedding ethics into research processes through practical tools, mentorship, and interdisciplinary partnerships. Strengthening these supports is essential to preparing the next generation of developers to design and deploy ethical AI in health care.
- 28 January 2026
- Published by JMIR Publications Inc. in Journal of Medical Internet Research
- Vol. 28, e79613
Open AccessEthical Knowledge, Challenges, and Institutional Strategies Among Medical AI Developers and Researchers: Focus Group Study
Background: As artificial intelligence (AI) becomes increasingly embedded in clinical decision-making and preventive care, it is urgent to address ethical concerns such as bias, privacy, and transparency to protect clinician and patient populations. Although prior research has examined the perspectives of medical AI stakeholders, including clinicians, patients, and health system leaders, far less is known about how medical AI developers and researchers understand and engage with ethical challenges as they develop AI tools. This gap is consequential because developers’ ethical awareness, decision-making, and institutional environments influence how AI tools are conceptualized and deployed in practice. Thus, it is essential to understand how developers perceive these issues and what supports they identify as necessary for ethical AI development. Objective: The objectives of the study were twofold: (1) to examine medical AI developers’ and researchers’ knowledge, attitudes, and experiences with AI ethics; and (2) to identify recommendations to enhance and strengthen interpersonal and institutional ethics-focused training and support. Methods: We conducted 2 semistructured focus groups (60-90 minutes each) in 2024 with 13 AI developers and researchers affiliated with 5 US-based academic institutions. Participants’ work spanned a wide variety of medical AI applications, including Alzheimer disease prediction, clinical imaging, electronic health records analysis, digital health, counseling and behavioral health, and genotype–phenotype modeling. Focus groups were conducted via Microsoft Teams, recorded, and transcribed verbatim. We applied conventional qualitative content analysis to inductively identify emerging concepts, categories, and themes. Coding was performed independently by 3 researchers, with consensus reached through iterative team meetings. Results: The analysis identified four key themes: (1) AI ethics knowledge acquisition: participants reported learning about ethics informally through peer-reviewed literature, reviewer feedback, social media, and mentorship rather than through structured training; (2) ethical encounters: participants described recurring ethical challenges related to data bias, patient privacy, generative AI use, commercialization pressures, and a tendency for research environments to prioritize model accuracy over ethical reflection; (3) reflections on ethical implications: participants expressed concern about downstream effects on patient care and clinician autonomy, and model generalizability, noting that rapid technological innovation outpaces regulatory and evaluative processes; and (4) strategies to mitigate ethical concerns: recommendations included clearer institutional guidelines, ethics checklists, interdisciplinary collaboration, multi-institutional data sharing, enhanced institutional review board support, and the inclusion of bioethicists as members of the AI research team. Conclusions: Medical AI developers and researchers recognize significant ethical challenges in their work but lack structured training, resources, and institutional mechanisms to address them. Findings of this study underscore the need for institutions to consider embedding ethics into research processes through practical tools, mentorship, and interdisciplinary partnerships. Strengthening these supports is essential to preparing the next generation of developers to design and deploy ethical AI in health care.
- Open Access
- 24 June 2025
- Published by JMIR Publications Inc. in JMIR Preprints
Ethical Knowledge, Challenges, and Institutional Strategies Among Medical AI Developers and Researchers: Focus Group Study (Preprint)
BACKGROUND As artificial intelligence (AI) becomes increasingly embedded in clinical decision-making and preventive care, it is urgent to address ethical concerns such as bias, privacy, and transparency to protect clinician and patient populations. Although prior research has examined the perspectives of medical AI stakeholders, including clinicians, patients, and health system leaders, far less is known about how medical AI developers and researchers understand and engage with ethical challenges as they develop AI tools. This gap is consequential because developers’ ethical awareness, decision-making, and institutional environments influence how AI tools are conceptualized and deployed in practice. Thus, it is essential to understand how developers perceive these issues and what supports they identify as necessary for ethical AI development. OBJECTIVE The objectives of the study were twofold: (1) to examine medical AI developers’ and researchers’ knowledge, attitudes, and experiences with AI ethics; and (2) to identify recommendations to enhance and strengthen interpersonal and institutional ethics-focused training and support. METHODS We conducted 2 semistructured focus groups (60-90 minutes each) in 2024 with 13 AI developers and researchers affiliated with 5 US-based academic institutions. Participants’ work spanned a wide variety of medical AI applications, including Alzheimer disease prediction, clinical imaging, electronic health records analysis, digital health, counseling and behavioral health, and genotype–phenotype modeling. Focus groups were conducted via Microsoft Teams, recorded, and transcribed verbatim. We applied conventional qualitative content analysis to inductively identify emerging concepts, categories, and themes. Coding was performed independently by 3 researchers, with consensus reached through iterative team meetings. RESULTS The analysis identified four key themes: (1) AI ethics knowledge acquisition: participants reported learning about ethics informally through peer-reviewed literature, reviewer feedback, social media, and mentorship rather than through structured training; (2) ethical encounters: participants described recurring ethical challenges related to data bias, patient privacy, generative AI use, commercialization pressures, and a tendency for research environments to prioritize model accuracy over ethical reflection; (3) reflections on ethical implications: participants expressed concern about downstream effects on patient care and clinician autonomy, and model generalizability, noting that rapid technological innovation outpaces regulatory and evaluative processes; and (4) strategies to mitigate ethical concerns: recommendations included clearer institutional guidelines, ethics checklists, interdisciplinary collaboration, multi-institutional data sharing, enhanced institutional review board support, and the inclusion of bioethicists as members of the AI research team. CONCLUSIONS Medical AI developers and researchers recognize significant ethical challenges in their work but lack structured training, resources, and institutional mechanisms to address them. Findings of this study underscore the need for institutions to consider embedding ethics into research processes through practical tools, mentorship, and interdisciplinary partnerships. Strengthening these supports is essential to preparing the next generation of developers to design and deploy ethical AI in health care. CLINICALTRIAL
- 24 June 2025
- Published by JMIR Publications Inc. in JMIR Preprints
Open AccessEthical Knowledge, Challenges, and Institutional Strategies Among Medical AI Developers and Researchers: Focus Group Study (Preprint)
BACKGROUND As artificial intelligence (AI) becomes increasingly embedded in clinical decision-making and preventive care, it is urgent to address ethical concerns such as bias, privacy, and transparency to protect clinician and patient populations. Although prior research has examined the perspectives of medical AI stakeholders, including clinicians, patients, and health system leaders, far less is known about how medical AI developers and researchers understand and engage with ethical challenges as they develop AI tools. This gap is consequential because developers’ ethical awareness, decision-making, and institutional environments influence how AI tools are conceptualized and deployed in practice. Thus, it is essential to understand how developers perceive these issues and what supports they identify as necessary for ethical AI development. OBJECTIVE The objectives of the study were twofold: (1) to examine medical AI developers’ and researchers’ knowledge, attitudes, and experiences with AI ethics; and (2) to identify recommendations to enhance and strengthen interpersonal and institutional ethics-focused training and support. METHODS We conducted 2 semistructured focus groups (60-90 minutes each) in 2024 with 13 AI developers and researchers affiliated with 5 US-based academic institutions. Participants’ work spanned a wide variety of medical AI applications, including Alzheimer disease prediction, clinical imaging, electronic health records analysis, digital health, counseling and behavioral health, and genotype–phenotype modeling. Focus groups were conducted via Microsoft Teams, recorded, and transcribed verbatim. We applied conventional qualitative content analysis to inductively identify emerging concepts, categories, and themes. Coding was performed independently by 3 researchers, with consensus reached through iterative team meetings. RESULTS The analysis identified four key themes: (1) AI ethics knowledge acquisition: participants reported learning about ethics informally through peer-reviewed literature, reviewer feedback, social media, and mentorship rather than through structured training; (2) ethical encounters: participants described recurring ethical challenges related to data bias, patient privacy, generative AI use, commercialization pressures, and a tendency for research environments to prioritize model accuracy over ethical reflection; (3) reflections on ethical implications: participants expressed concern about downstream effects on patient care and clinician autonomy, and model generalizability, noting that rapid technological innovation outpaces regulatory and evaluative processes; and (4) strategies to mitigate ethical concerns: recommendations included clearer institutional guidelines, ethics checklists, interdisciplinary collaboration, multi-institutional data sharing, enhanced institutional review board support, and the inclusion of bioethicists as members of the AI research team. CONCLUSIONS Medical AI developers and researchers recognize significant ethical challenges in their work but lack structured training, resources, and institutional mechanisms to address them. Findings of this study underscore the need for institutions to consider embedding ethics into research processes through practical tools, mentorship, and interdisciplinary partnerships. Strengthening these supports is essential to preparing the next generation of developers to design and deploy ethical AI in health care. CLINICALTRIAL
- 21 June 2025
- Published by Oxford University Press (OUP) in Journal of Public Health
- Vol. 47 (3) , 594-601
Investigating the link between COVID-19 misinformation exposure and vaccine hesitancy through perceptions of efficacy and unsafety
Background: Misinformation has played a significant role in shaping public attitudes toward COVID-19 vaccines, contributing to vaccine hesitancy. This study examines the relationship between misinformation exposure and vaccine hesitancy, focusing on the mediating roles of perceived vaccine safety and efficacy. Additionally, it explores how trust in misinformation influences these relationships. Methods: A cross-sectional survey was conducted between March and May 2021 across four university campuses in the southeastern United States (N = 819). Participants (Mean age = 20.55, SD = 2.85) were predominantly female (N = 525, 64.1%). Mediation and moderated mediation analyses were performed using Hayes’ PROCESS Model 4 and Model 8. Results: Findings revealed that greater exposure to vaccine misinformation was associated with higher vaccine hesitancy. This relationship was mediated by increased perceptions of vaccine unsafety and reduced beliefs in vaccine efficacy. Additionally, trust in misinformation strengthened the indirect effect through perceived vaccine unsafety, reinforcing hesitancy among individuals who found misinformation more credible. Conclusion: This study highlights the critical role of misinformation in shaping vaccine hesitancy. By identifying the psychological mechanisms underlying this relationship, these insights can inform strategies to counter misinformation, improve public trust in vaccines, and enhance health communication in future public health crises.
- 21 June 2025
- Published by Oxford University Press (OUP) in Journal of Public Health
- Vol. 47 (3) , 594-601
Investigating the link between COVID-19 misinformation exposure and vaccine hesitancy through perceptions of efficacy and unsafety
Background: Misinformation has played a significant role in shaping public attitudes toward COVID-19 vaccines, contributing to vaccine hesitancy. This study examines the relationship between misinformation exposure and vaccine hesitancy, focusing on the mediating roles of perceived vaccine safety and efficacy. Additionally, it explores how trust in misinformation influences these relationships. Methods: A cross-sectional survey was conducted between March and May 2021 across four university campuses in the southeastern United States (N = 819). Participants (Mean age = 20.55, SD = 2.85) were predominantly female (N = 525, 64.1%). Mediation and moderated mediation analyses were performed using Hayes’ PROCESS Model 4 and Model 8. Results: Findings revealed that greater exposure to vaccine misinformation was associated with higher vaccine hesitancy. This relationship was mediated by increased perceptions of vaccine unsafety and reduced beliefs in vaccine efficacy. Additionally, trust in misinformation strengthened the indirect effect through perceived vaccine unsafety, reinforcing hesitancy among individuals who found misinformation more credible. Conclusion: This study highlights the critical role of misinformation in shaping vaccine hesitancy. By identifying the psychological mechanisms underlying this relationship, these insights can inform strategies to counter misinformation, improve public trust in vaccines, and enhance health communication in future public health crises.
- 4 June 2025
- Published by Springer Nature
- p. 211-221
Enhancing AI Ethics Education: Developing a VR Application to Teach Ethical Principles and Practices to AI Researchers
- 4 June 2025
- Published by Springer Nature
- p. 211-221
Enhancing AI Ethics Education: Developing a VR Application to Teach Ethical Principles and Practices to AI Researchers
- 3 January 2025
- Published by Taylor & Francis in Health Communication
- p. 1-12
“I Want to Hold an Umbrella Over You Because I Have Been in the Rain”: Exploring Patient Influencers’ Motivations to Share Eating Disorders Experiences from a Self-Determination Theory Perspective
Patients can become educator-influencers in promoting the public's understanding of health and illness; however, the underlying motivations driving their engagement in this role remain unclear. Drawing from the Self-Determination Theory, this study explores the motivations of patients-turned-influencers in sharing eating disorders (ED) experiences and information on Chinese social media. Through semi-structured interviews with 33 patient influencers, this study examines the motivations associated with three psychological needs: autonomy, competence, and relatedness. In terms of autonomy, influencers shared their ED experiences as self-therapy, expression, and documentation of personal growth. Regarding competence, influencers felt that their medical training or personal experiences made them more knowledgeable about ED, and their communication skills and high self-esteem gave them more confidence and courage to share their ED experiences. Finally, in terms of relatedness, altruism, community building, and peer influence are the driving forces behind their sharing behaviors. With the rise of ED cases in China, misunderstandings about the condition remain prevalent. As the first study of ED social media influencers in a Chinese context, this research highlights the unique cultural and social factors influencing the motivations behind sharing ED-related experiences on social media. The theoretical and practical implications of the study are also discussed.
- 3 January 2025
- Published by Taylor & Francis in Health Communication
- p. 1-12
“I Want to Hold an Umbrella Over You Because I Have Been in the Rain”: Exploring Patient Influencers’ Motivations to Share Eating Disorders Experiences from a Self-Determination Theory Perspective
Patients can become educator-influencers in promoting the public's understanding of health and illness; however, the underlying motivations driving their engagement in this role remain unclear. Drawing from the Self-Determination Theory, this study explores the motivations of patients-turned-influencers in sharing eating disorders (ED) experiences and information on Chinese social media. Through semi-structured interviews with 33 patient influencers, this study examines the motivations associated with three psychological needs: autonomy, competence, and relatedness. In terms of autonomy, influencers shared their ED experiences as self-therapy, expression, and documentation of personal growth. Regarding competence, influencers felt that their medical training or personal experiences made them more knowledgeable about ED, and their communication skills and high self-esteem gave them more confidence and courage to share their ED experiences. Finally, in terms of relatedness, altruism, community building, and peer influence are the driving forces behind their sharing behaviors. With the rise of ED cases in China, misunderstandings about the condition remain prevalent. As the first study of ED social media influencers in a Chinese context, this research highlights the unique cultural and social factors influencing the motivations behind sharing ED-related experiences on social media. The theoretical and practical implications of the study are also discussed.